Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AAIPharma Acquires Xcelodose 600S system | Contract Pharma

What are you searching for?

Sign in
Breaking News

AAIPharma Acquires Xcelodose 600S system

AAIPharma has acquired the Xcelodose 600S capsule filling system, enhancing the company’s preclinical and early phase clinical GMP supply capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AAIPharma has acquired the Xcelodose 600S capsule filling system, enhancing the company’s preclinical and early phase clinical GMP supply capabilities. The Xcelodose 600S can accommodate batch sizes up to several thousand capsules in sizes from 00 to size 4 with a variety of fills including neat drug substance, granulations, and blends.

Some of the benefits this technology provides include: decreased development time with clinical supplies available in less than three months; reduced active ingredient requirements through dosing into capsules reducing waste; reduced cleaning requirements through the use of dedicated product contact parts; and lower potential for stability issues by eliminating the possibility of excipient interactions and uniformity problems.

The company plans to install the unit in its solid dose manufacturing facility in Wilmington, NC within a specially designed containment system that will allow for enhanced operator safety. The unit is expected to be available and validated by June 2009. Xcelodose is 21CFR Part 11 compliant.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics